Evaluating laboratory criteria for combined immunodeficiency in adult patients diagnosed with common variable...

Area of Science:

• Immunology
• Clinical Medicine
• T-cell research

Background:

• Common variable immunodeficiency (CVID) is a heterogeneous group of primary immunodeficiencies.
• Some CVID patients may have underlying combined immunodeficiency (CID), necessitating distinct therapeutic strategies.
• Accurate differentiation between CVID and CID is crucial for appropriate patient management.

Purpose of the Study:

• To evaluate the efficacy of existing CD4 T-cell-based criteria in distinguishing CID from CVID in adult patients.
• To identify reliable immunological markers for diagnosing CID within the CVID cohort.

Main Methods:

• Retrospective analysis of immunological and clinical data from 238 adult CVID patients.
• Comparison of four proposed CD4 T-cell-based definitions for identifying CID.
• Assessment of marker sensitivity for clinical complications associated with CID.

Main Results:

• None of the evaluated criteria effectively separated CID from CVID patients.
• A relative reduction in naive CD4 T cells below 10% showed the highest sensitivity for identifying patients with CID-related clinical complications.
• Low naive CD4 T-cell counts warrant suspicion but are insufficient for a definitive CID diagnosis.

Conclusions:

• Current CD4 T-cell-based definitions are inadequate for differentiating CID from CVID in adult patients.
• While a low percentage of naive CD4 T cells is a potential indicator, it cannot solely define CID.
• Further research is needed to develop more precise diagnostic tools for combined immunodeficiency.